Rapid Influenza Diagnostic Test (RIDT) Market Share, Sales Volume, Price Analysis Report 2026
On Feb 13, the latest report "Global Rapid Influenza Diagnostic Test (RIDT) Market 2026 by Manufacturers, Regions, Types and Applications, Forecast to 2032" from Global Info Research provides a detailed and comprehensive analysis of the global Rapid Influenza Diagnostic Test (RIDT) market. The report provides both quantitative and qualitative analysis by manufacturers, regions and countries, types and applications. As the market is constantly changing, this report explores market competition, supply and demand trends, and key factors that are causing many market demand changes. The report also provides company profiles and product examples of some of the competitors, as well as market share estimates for some of the leading players in 2026.
Get Report Sample with Industry Insights https://www.globalinforesearch.com/reports/3112677/rapid-influenza-diagnostic-test--ridt
According to our (Global Info Research) latest study, the global Rapid Influenza Diagnostic Test (RIDT) market size was valued at US$ 1185 million in 2024 and is forecast to a readjusted size of USD 1901 million by 2031 with a CAGR of 6.8% during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Rapid Influenza Diagnostic Tests (RIDTs) are in vitro diagnostic products based on immunochromatographic or immunofluorescence technology, designed to qualitatively detect the presence of Influenza A and B nucleoprotein antigens in respiratory specimens within 30 minutes. Product formats mainly include lateral-flow cassette tests, fluorescent immunoassay cartridges, and multiplex panels (e.g., Flu A/B + SARS-CoV-2). Upstream materials primarily consist of monoclonal and polyclonal antibodies, antigen controls, nitrocellulose membranes, plastic housings, and buffer reagents, supplied by specialized reagent and medical consumable manufacturers. Downstream clients include hospital laboratories, community clinics, pharmacies and OTC retailers, public health agencies, and home-testing users.
Based on due-diligence estimates, the global RIDT market in 2024 had an installed production capacity of approximately 320 million units, with sales of around 256 million units. The average selling price was about USD 4.5 per unit, and the average gross margin was approximately 67%. The market continues to grow steadily, driven by recurring flu seasons, enhanced epidemic surveillance, and rising demand for rapid self-testing. With the adoption of multiplex combo tests (e.g., Flu/COVID/RSV) and more sensitive fluorescent immunoassay platforms, the industry is expected to experience further consolidation and technological upgrading.
At present, the global Rapid Influenza Diagnostic Test (RIDT) market is experiencing steady expansion. Frequent mutations in influenza virus strains and the predictable recurrence of seasonal flu outbreaks have increased the demand for rapid testing among public health systems and medical institutions worldwide. RIDTs are gaining wider adoption across hospitals, community clinics, and home-testing scenarios. Since the COVID-19 pandemic, public awareness and acceptance of respiratory virus rapid testing have grown substantially, further driving RIDT utilization. In addition, regulatory authorities in several countries have relaxed approval processes for over-the-counter (OTC) diagnostic products, enabling faster penetration of home-use testing kits.
Looking ahead, the RIDT market is expected to evolve toward multiplex detection and higher sensitivity. With technological advancements, more manufacturers are integrating influenza testing with other respiratory pathogens such as COVID-19, RSV, and adenovirus, allowing “one-sample, multi-target” diagnostics. The integration of digital connectivity will enable real-time data transmission and improve epidemic surveillance efficiency. Meanwhile, emerging Asian markets—supported by large populations and improving primary healthcare infrastructure—are anticipated to become the main growth drivers for global RIDT demand.
Nevertheless, several challenges remain. RIDTs still show lower sensitivity and specificity compared with molecular diagnostic methods such as RT-PCR, leading to potential false negatives in some cases. Price fluctuations in raw materials, high supplier concentration, and varying regulatory standards across regions can increase operational risks and cost pressures for manufacturers. Additionally, rising product homogeneity intensifies market competition, making it difficult for smaller players to achieve economies of scale. Going forward, industry growth will increasingly depend on continuous technological innovation, product diversification, and robust compliance in quality management and regulatory frameworks.
This report is a detailed and comprehensive analysis for global Rapid Influenza Diagnostic Test (RIDT) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approval.
Rapid Influenza Diagnostic Test (RIDT) market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type: Immunochromatography、 Colloidal Gold Method、 Others
Market segment by Application: Hospital、 Clinics、 Home、 Others
Major players covered: BD、 Abbott、 Quidel、 Actim、 Denka、 Roche、 Thermo Fisher Scientific、 Meridian Bioscience、 Sekisui Diagnostics、 Princeton BioMeditech、 Access Bio、 Response Biomedical、 Guangzhou Wondfo Biotech、 Jiangsu Bioperfectus Technologies、 Hangzhou Biotest Biotech、 Wantai BioPharm、 Daan Gene、 Kehua Bio-Engineering、 Zhuhai Encode Medical Engineering
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Rapid Influenza Diagnostic Test (RIDT) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Rapid Influenza Diagnostic Test (RIDT), with price, sales quantity, revenue, and global market share of Rapid Influenza Diagnostic Test (RIDT) from 2021 to 2026.
Chapter 3, the Rapid Influenza Diagnostic Test (RIDT) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Rapid Influenza Diagnostic Test (RIDT) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment Rapid Influenza Diagnostic Test (RIDT) the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the Rapid Influenza Diagnostic Test (RIDT) sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2025.and Rapid Influenza Diagnostic Test (RIDT) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Rapid Influenza Diagnostic Test (RIDT).
Chapter 14 and 15, to describe Rapid Influenza Diagnostic Test (RIDT) sales channel, distributors, customers, research findings and conclusion.
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Rapid Influenza Diagnostic Test (RIDT)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
Global Info Research is a company that digs deep into global industry information to support enterprises with market strategies and in-depth market development analysis reports. We provides market information consulting services in the global region to support enterprise strategic planning and official information reporting, and focuses on customized research, management consulting, IPO consulting, industry chain research, database and top industry services. At the same time, Global Info Research is also a report publisher, a customer and an interest-based suppliers, and is trusted by more than 30,000 companies around the world. We will always carry out all aspects of our business with excellent expertise and experience.
Contact Us:
Global Info Research
Web: https://www.globalinforesearch.com
Email: report@globalinforesearch.com
Get Report Sample with Industry Insights https://www.globalinforesearch.com/reports/3112677/rapid-influenza-diagnostic-test--ridt
According to our (Global Info Research) latest study, the global Rapid Influenza Diagnostic Test (RIDT) market size was valued at US$ 1185 million in 2024 and is forecast to a readjusted size of USD 1901 million by 2031 with a CAGR of 6.8% during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Rapid Influenza Diagnostic Tests (RIDTs) are in vitro diagnostic products based on immunochromatographic or immunofluorescence technology, designed to qualitatively detect the presence of Influenza A and B nucleoprotein antigens in respiratory specimens within 30 minutes. Product formats mainly include lateral-flow cassette tests, fluorescent immunoassay cartridges, and multiplex panels (e.g., Flu A/B + SARS-CoV-2). Upstream materials primarily consist of monoclonal and polyclonal antibodies, antigen controls, nitrocellulose membranes, plastic housings, and buffer reagents, supplied by specialized reagent and medical consumable manufacturers. Downstream clients include hospital laboratories, community clinics, pharmacies and OTC retailers, public health agencies, and home-testing users.
Based on due-diligence estimates, the global RIDT market in 2024 had an installed production capacity of approximately 320 million units, with sales of around 256 million units. The average selling price was about USD 4.5 per unit, and the average gross margin was approximately 67%. The market continues to grow steadily, driven by recurring flu seasons, enhanced epidemic surveillance, and rising demand for rapid self-testing. With the adoption of multiplex combo tests (e.g., Flu/COVID/RSV) and more sensitive fluorescent immunoassay platforms, the industry is expected to experience further consolidation and technological upgrading.
At present, the global Rapid Influenza Diagnostic Test (RIDT) market is experiencing steady expansion. Frequent mutations in influenza virus strains and the predictable recurrence of seasonal flu outbreaks have increased the demand for rapid testing among public health systems and medical institutions worldwide. RIDTs are gaining wider adoption across hospitals, community clinics, and home-testing scenarios. Since the COVID-19 pandemic, public awareness and acceptance of respiratory virus rapid testing have grown substantially, further driving RIDT utilization. In addition, regulatory authorities in several countries have relaxed approval processes for over-the-counter (OTC) diagnostic products, enabling faster penetration of home-use testing kits.
Looking ahead, the RIDT market is expected to evolve toward multiplex detection and higher sensitivity. With technological advancements, more manufacturers are integrating influenza testing with other respiratory pathogens such as COVID-19, RSV, and adenovirus, allowing “one-sample, multi-target” diagnostics. The integration of digital connectivity will enable real-time data transmission and improve epidemic surveillance efficiency. Meanwhile, emerging Asian markets—supported by large populations and improving primary healthcare infrastructure—are anticipated to become the main growth drivers for global RIDT demand.
Nevertheless, several challenges remain. RIDTs still show lower sensitivity and specificity compared with molecular diagnostic methods such as RT-PCR, leading to potential false negatives in some cases. Price fluctuations in raw materials, high supplier concentration, and varying regulatory standards across regions can increase operational risks and cost pressures for manufacturers. Additionally, rising product homogeneity intensifies market competition, making it difficult for smaller players to achieve economies of scale. Going forward, industry growth will increasingly depend on continuous technological innovation, product diversification, and robust compliance in quality management and regulatory frameworks.
This report is a detailed and comprehensive analysis for global Rapid Influenza Diagnostic Test (RIDT) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approval.
Rapid Influenza Diagnostic Test (RIDT) market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type: Immunochromatography、 Colloidal Gold Method、 Others
Market segment by Application: Hospital、 Clinics、 Home、 Others
Major players covered: BD、 Abbott、 Quidel、 Actim、 Denka、 Roche、 Thermo Fisher Scientific、 Meridian Bioscience、 Sekisui Diagnostics、 Princeton BioMeditech、 Access Bio、 Response Biomedical、 Guangzhou Wondfo Biotech、 Jiangsu Bioperfectus Technologies、 Hangzhou Biotest Biotech、 Wantai BioPharm、 Daan Gene、 Kehua Bio-Engineering、 Zhuhai Encode Medical Engineering
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Rapid Influenza Diagnostic Test (RIDT) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Rapid Influenza Diagnostic Test (RIDT), with price, sales quantity, revenue, and global market share of Rapid Influenza Diagnostic Test (RIDT) from 2021 to 2026.
Chapter 3, the Rapid Influenza Diagnostic Test (RIDT) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Rapid Influenza Diagnostic Test (RIDT) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment Rapid Influenza Diagnostic Test (RIDT) the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the Rapid Influenza Diagnostic Test (RIDT) sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2025.and Rapid Influenza Diagnostic Test (RIDT) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Rapid Influenza Diagnostic Test (RIDT).
Chapter 14 and 15, to describe Rapid Influenza Diagnostic Test (RIDT) sales channel, distributors, customers, research findings and conclusion.
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Rapid Influenza Diagnostic Test (RIDT)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
Global Info Research is a company that digs deep into global industry information to support enterprises with market strategies and in-depth market development analysis reports. We provides market information consulting services in the global region to support enterprise strategic planning and official information reporting, and focuses on customized research, management consulting, IPO consulting, industry chain research, database and top industry services. At the same time, Global Info Research is also a report publisher, a customer and an interest-based suppliers, and is trusted by more than 30,000 companies around the world. We will always carry out all aspects of our business with excellent expertise and experience.
Contact Us:
Global Info Research
Web: https://www.globalinforesearch.com
Email: report@globalinforesearch.com
